Tag:
Paras Pharmaceuticals
Latest Headlines
Latest Headlines
GSK nabs Maxinutrition; Reckitt pays $726M for Paras
A couple of consumer-health deals underscore pharma's ongoing rush to diversify. First, GlaxoSmithKline ( $GSK ) has bought a protein-drinks firm, Maxinutrition, for 162 million pounds ($255.7
Big Pharma, Soros in emerging-markets deals
Some big names have cropped up in a new round of emerging-markets investments. First, there's Sihuan Pharmaceutical, the Chinese drugmaker that's going public in Hong Kong. Not only was the IPO fully
Japan's Taisho in lead to buy Paras Pharma
Japan's Taisho Pharmaceuticals has emerged the top bidder to buy a majority stake in Indian drugmaker Paras Pharmaceuticals, which owns popular brands such as anti-cold medication D'Cold and pain
